Borel & Barbey with NeuroGyn on series A financing round
Borel & Barbey advised NeuroGyn in connection with a series A financing round of CHF 4 million, led by a Swiss institutional investor.
The company
Founded by Marc Possover, a specialist in pelvic nerve surgery and the founder of the field of neuropelveology, NeuroGyn is a Swiss medical technology company developing a proprietary neuromodulation platform designed to expand access to pelvic neuromodulation, particularly in women’s health. Its technology aims to improve the quality of life of patients affected by pelvic organ dysfunction through innovative, minimally invasive neuromodulation.
The round
The financing round was led by a Swiss institutional investor active in the medical technology sector, alongside private investors. The proceeds of the financing will be used, in particular, to initiate human clinical studies, advance regulatory development, and accelerate NeuroGyn AG’s proprietary neuromodulation platform toward commercialisation.
The advisory team
Borel & Barbey’s team on the matter included partner Pierre Turrettini and associate Raoul de Montpellier, both from the firm’s corporate practice.
